BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 33523318)

  • 21. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
    Bozio CH; Grannis SJ; Naleway AL; Ong TC; Butterfield KA; DeSilva MB; Natarajan K; Yang DH; Rao S; Klein NP; Irving SA; Dixon BE; Dascomb K; Liao IC; Reynolds S; McEvoy C; Han J; Reese SE; Lewis N; Fadel WF; Grisel N; Murthy K; Ferdinands J; Kharbanda AB; Mitchell PK; Goddard K; Embi PJ; Arndorfer J; Raiyani C; Patel P; Rowley EA; Fireman B; Valvi NR; Griggs EP; Levy ME; Zerbo O; Porter RM; Birch RJ; Blanton L; Ball SW; Steffens A; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron M; Gaglani M; Thompson MG; Stenehjem E
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1539-1544. PubMed ID: 34735425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
    DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
    Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients.
    Newman AM; Jhaveri R; Patel AB; Tan TQ; Toia JM; Arshad M
    J Pediatr; 2021 Jan; 228():294-296. PubMed ID: 32861693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective review of the code status of individuals with Down syndrome during the COVID-19 era.
    Jett J; Fossi A; Blonsky H; Ross W; Townsend S; Stephens MM; Chicoine B; Santoro SL
    Am J Med Genet C Semin Med Genet; 2024 Mar; 196(1):e32080. PubMed ID: 38087874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.
    Mah J; Lieu A; Palayew M; Alipour P; Kong LY; Song S; Palayew A; Tutt-Guérette MA; Yang SS; Wilchesky M; Lipes J; Azoulay L; Greenaway C
    CMAJ Open; 2021; 9(3):E718-E727. PubMed ID: 34257090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran.
    Abolnezhadian F; Makvandi M; Alavi SM; Azaran A; Jalilian S; Rashno M; Kaydani GA; Arshadi M; Hosseinizadeh SM; Boostani H; Seyedian SS; Moogahi S; Salmanzadeh S; Varnaseri M; Neisi N; Keifarrokhi H; Shariati G; Amiri H; Parsanahad M; Nashibi R; Yousefi F; Ahmadi F; AhmadiAngali K
    Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):471-477. PubMed ID: 33463114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
    Abrishami M; Tohidinezhad F; Daneshvar R; Omidtabrizi A; Amini M; Sedaghat A; Amini S; Reihani H; Allahyari A; Seddigh-Shamsi M; Tayyebi M; Naderi H; Bojdy A; Khodashahi R; Eslami S
    Ocul Immunol Inflamm; 2020 Jul; 28(5):739-744. PubMed ID: 32569494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?
    Pavlidis G; Kampolis CF; Perlepe G; Pagonis A; Maniotis C; Koullias E; Kranidioti H; Kyritsis A; Pavlou E; Sinis S; Pirounaki M; Vassilopoulos D; Gourgoulianis K; Pantazopoulos I
    In Vivo; 2022; 36(4):1944-1948. PubMed ID: 35738610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study.
    Kumar RN; Wu EL; Stosor V; Moore WJ; Achenbach C; Ison MG; Angarone MP
    Clin Infect Dis; 2022 Jan; 74(1):24-31. PubMed ID: 33846730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Over 60 years of age as an independent prognostic factor of in-hospital mortality among COVID-19 patients: a cohort study in an Iranian high-incidence area.
    Navayi M; Fanoodi A; Salmani F; Abedi F; Shetty S; Riahi SM
    Public Health; 2021 Nov; 200():33-38. PubMed ID: 34656815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends of in-hospital and ICU mortality in COVID-19 patients over the fourth and fifth COVID-19 surges in Iran: a retrospective cohort study from Iran.
    Abdi S; Nemati S; Nederi Darbaghshahi N; Mohammadi M; Saeedi E; Naji P; Taheri N; Qandian A; Joshang N; Fattahi P; Namdar P; Vand Rajabpour M
    Int J Qual Health Care; 2022 Aug; 34(3):. PubMed ID: 35880708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
    Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
    Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study.
    Omrani AS; Almaslamani MA; Daghfal J; Alattar RA; Elgara M; Shaar SH; Ibrahim TBH; Zaqout A; Bakdach D; Akkari AM; Baiou A; Alhariri B; Elajez R; Husain AAM; Badawi MN; Abid FB; Abu Jarir SH; Abdalla S; Kaleeckal A; Choda K; Chinta VR; Sherbash MA; Al-Ismail K; Abukhattab M; Ait Hssain A; Coyle PV; Bertollini R; Frenneaux MP; Alkhal A; Al-Kuwari HM
    BMC Infect Dis; 2020 Oct; 20(1):777. PubMed ID: 33076848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Manifestations, Imaging Procedures and Laboratory Parameters among Hospitalized Patients with COVID-19 in Ilam Province, Western Iran.
    Kaffashian MR; Shirani M; Koupaei M; Sadeghifard N; Ahmadi I; Mozafari A; Nazari A; Heidary M; Khoshnood S
    Ethiop J Health Sci; 2022 May; 32(3):485-496. PubMed ID: 35813682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Bergman J; Ballin M; Nordström A; Nordström P
    Eur J Epidemiol; 2021 Mar; 36(3):287-298. PubMed ID: 33704634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Paradox of the Low Prevalence of Current Smokers Among COVID-19 Patients Hospitalized in Nonintensive Care Wards: Results From an Italian Multicenter Case-Control Study.
    Meini S; Fortini A; Andreini R; Sechi LA; Tascini C
    Nicotine Tob Res; 2021 Aug; 23(8):1436-1440. PubMed ID: 32964233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts.
    McCarty TR; Hathorn KE; Redd WD; Rodriguez NJ; Zhou JC; Bazarbashi AN; Njie C; Wong D; Trinh QD; Shen L; Stone VE; Chan WW
    Clin Infect Dis; 2021 Dec; 73(11):e4131-e4138. PubMed ID: 32827436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.